Navigation Links
WHO: Lives At Risk In Sudan As Diseases Soar, Call for Funding

The World Health Organization (WHO) has called for more funds to combat the major outbreaks of cholera and meningitis, which has put the lives of millions of people at risk in Sudan//.

If appropriate health control measures are not instituted at the earliest, the incidence and prevalence of these deadly diseases is only expected to accelerate in the forthcoming weeks. Currently, Sudan is dependent on other nations to help ease its financial burden worth 13.8 million pounds or $24 million.

'Adverse consequences for the health of millions of people throughout Sudan' has been predicted by the United Nations agency, unless funds flood in for the 20 health projects that have been planned.

'Over the last six months, Sudan has experienced major outbreaks of epidemic diseases such as acute watery diarrhoea and cholera, dengue, yellow fever, monkey pox and meningitis, placing additional strains on already stretched health care services,' read a statement prepared by the International health agency.

The lack of essential drugs and vaccinations is believed to further spread meningitis, a disease characterized by inflammation of the coverings surrounding the brain and spinal cord. At least 1, 335 people have been feared infected with meningitis that commonly spread through close contact with an infected person, and acts such as sneezing and coughing.

An acute outbreak of diarrhoea (watery diarrhoea) has claimed the lives of nearly 248 lives and infected 9, 400 others, across the 10 different states in southern Sudan, according to a health report by the WHO. In addition, a number of new cases are being reported everyday in new locations, much to the concern of the health officials.

Cholera, a water borne disease characterized by vomiting and acute diarrhea can have a fatal consequence if the dehydration is not attended to immediately (within 24 hours). No clear reports about incidence of cholera have been obtained so far.


'"/>




Related medicine news :

1. Painkillers Do Not Shorten Dying Patients Lives
2. Ebola Virus - Outbreak Claims More Lives In Uganda.
3. B Vitamin Supplementatoin Saves Money and Lives
4. Encephalitis Has Claimed 400 Lives In Uttar Pradesh
5. Dengue Claims 15 Lives In West Bengal
6. Dead Palestinian Boy Saves Lives Of Six Others
7. Dengue Fever Claims Five Lives In Pakistan
8. Pneumonia Claims 30 Lives In Pakistan
9. Encephalitis Claims 25 Lives In Bihar
10. Tamiflu Fails To Save Two Lives
11. Decoding the Fungi Genome Will Save Millions of Lives.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... , ... The American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) ... Health Care Quality and Management and Patient Safety. , It is with appreciation and ... also to the Health Care Quality and Patient Safety movements. Diplomates and Members lead ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April ... , How will the new EU MDR language change the way manufacturers ...
(Date:3/23/2017)... ... , ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous ... Bonetta Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures ... Rose‘s new book presents actual events in the life of her family, which validate ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... the existence of God. “A Respectful Response To Atheist Manifesto” is the creation ... married to his wife, Nancy, for sixty years. He holds graduate degrees from ...
(Date:3/22/2017)... ... March 23, 2017 , ... Death anxiety is unconscious ... profession, author Joy Nugent was inspired to write the book titled “ As Good ... inward desire to make sense of what she was experiencing at the bedside of ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") ... is pleased to announce that its majority-owned subsidiary, ... U.S. Food and Drug Administration (FDA) for the ... tablets in the 12.5 mg and 25 mg ... equivalent of the branded product Xenazine ® ...
(Date:3/23/2017)... ReNeuron reported in December 2016 positive ... stroke patients, despite not meeting the three-month time frame of ... Research Arm Test (ARAT). As a result, the company has ... study in 2017. Beyond CTX, we expect safety and efficacy ... Phase I data from its critical limb ischaemia (CLI) trial. ...
(Date:3/23/2017)... , Mar 23, 2017 The Board ... to the Annual General Meeting, which is to take place on ... 2 in Lund, Sweden . ... Please see the attached notification, which ... Inrikes Tidningar. NeuroVive Pharmaceutical AB (Publ) The Board Of ...
Breaking Medicine Technology: